The endocrinology drugs market is expected to grow by USD 25.25 billion during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the endocrinology drugs market in optimistic, probable, and pessimistic forecast scenarios.
The endocrinology drugs market will witness a neutral impact during the forecast period owing to the widespread growth of the COVID-19 pandemic. As per Technavio's pandemic-focused market research, market growth is likely to increase in 2021 as compared to 2020.
With the continuing spread of the coronavirus pandemic, organizations across the globe are gradually flattening their recessionary curve by leveraging technology. Many businesses will go through response, recovery, and renewal phases. Building business resilience and enabling agility will aid organizations to move forward in their journey out of the COVID-19 crisis towards the Next Normal.
Key Considerations for Market Forecast:
Impact of lockdowns, supply chain disruptions, demand destruction, and change in customer behavior
Optimistic, probable, and pessimistic scenarios for all markets as the impact of pandemic unfolds
Pre- as well as post-COVID-19 market estimates
Quarterly impact analysis and updates on market estimates
The endocrinology drugs market is driven by the increase in the incidence of endocrine disorders. In addition, ongoing research in novel dosage formulations and drug delivery systems are expected to trigger the endocrinology drugs market toward witnessing a CAGR of over 6% during the forecast period.
Global Endovenous Ablation Devices Market - Global endovenous ablation devices market is segmented by product (EVLT devices, RFA devices, and NTNT devices) and geography (North America, Europe, Asia, and ROW). Request a Free Sample Report
Global Neuroendovascular Coils Market- Global neuroendovascular coils market is segmented by Product (GDC and Matrix coil) and Geography (North America, Europe, Asia, and ROW). Request a Free Sample Report
Market positioning of vendors
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.